![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Guggenberger, J.; Kenndoff, S.; Taugner, J.; Käsmann, Lukas; Flörsch, B.; Belka, C.; Eze, C. und Manapov, F.
(24. März 2022):
Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab.
In: BMC Cancer, Bd. 22
[PDF, 1MB]
Manapov, F. und Eze, C.
(2017):
Survival advantage for etoposide/cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest.
In: Annals of Oncology, Bd. 28, Nr. 9: S. 2319-2320
Roengvoraphoj, O.; Eze, C.; Fendler, W.; Dantes, M.; Belka, C. und Manapov, F.
(2017):
Prognostic value of pre-to post-treatment primary tumor metabolic volume reduction on 18F-FDG-PET/CT in a patient cohort with inoperable locally-advanced NSCLC treated with definitive chemoradiotherapy.
In: Annals of Oncology, Bd. 28
Roengvoraphoj, O.; Eze, C.; Wijaya, C.; Fendler, W.; Belka, C. und Manapov, F.
(2017):
Prognostic value of pre- to posttreatment primary tumor metabolic volume reduction on 18F-FDG-PET/CT in a homogeneous patient cohort with inoperable locally-advanced non-small cell lung cancer treated with definitive chemoradiotherapy.
In: Strahlentherapie und Onkologie, Bd. 193:
S144-S144
Roengvoraphoj, O.; Eze, C.; Li, M. und Manapov, F.
(2017):
Symptomatic pneumonitis in the irradiated lung after nivolumab: case study.
In: Strahlentherapie und Onkologie, Bd. 193:
S143-S143
Roengvoraphoj, O.; Eze, C.; Li, M. und Manapov, F.
(2017):
Symptomatic pneumonitis in the irradiated lung after nivolumab: Three case studies.
In: Annals of Oncology, Bd. 28
Roengvoraphoj, O.; Wijaya, C.; Eze, C.; Fendler, W.; Gerum, S.; Belka, C. und Manapov, F.
(2016):
Impact of the primary tumor metabolic volume (PT-MV) changes in the course of multimodality treatment on overall survival in patients with locally-advanced non-small cell lung cancer.
In: Journal of thoracic Oncology, Bd. 11, Nr. 4:
S109-S109
Eze, C.; Roengvoraphoj, O.; Gerum, S.; Belka, C. und Manapov, F.
(2016):
Maximum treatment response and prophylactic cranial irradiation are important prognostic factors in limited disease small-cell lung cancer patients comprehensively staged with cranial magnetic resonance imaging.
In: Journal of thoracic Oncology, Bd. 11, Nr. 4:
S111-S111